---

Efficacy of nalbuphine for suppression of hemodynamic responses to pneumoperitoneum- A prospective randomised controlled study

Full Text PDF

---

Original Article

Author Details : Meghna Singhal, Rajesh Singh Rautela, Rashmi Salhotra*, Kshitiz Hirani, Mahendra Kumar

Volume : 10, Issue : 1, Year : 2023

Article Page : 58-63

https://doi.org/10.18231/j.ijca.2023.011

Suggest article by email

Get Permission

Abstract

Background and Aim: Pneumoperitoneum created during laparoscopic surgeries induces significant hemodynamic changes. This study was aimed to explore the efficacy of nalbuphine to suppress hemodynamic responses to pneumoperitoneum.
Materials and Methods: This was a prospective randomised controlled study conducted on 80 ASA I/II patients between 18-60 yr after institutional ethics committee approval and written informed consent. Presence of pregnancy, multiple drug therapy, cardiovascular, renal or hepatic diseases were taken as exclusion criteria. Based on a computer-generated random number table patients were allocated to one of the two groups; Group N: Nalbuphine 0.3 mg/kg and Group S: Normal saline. Hemodynamic parameters, time to request of rescue analgesic, sedation and side effects were recorded. Data was analysed using student t-test and Chi square/Fisher’s exact test, repeated measure ANOVA. A p-value<0> Results: Group N patients had lower heart rate after test drug and for the first 30 min and on deflation of pneumoperitoneum. The mean and systolic blood pressure decreased at the time of creation of pneumoperitoneum (p<0 p=0.004). p=0.002).> Conclusion: Nalbuphine provides stable hemodynamics for first 30 min after creation of pneumoperitoneum for laparoscopic procedures. It also provides postoperative analgesia for a short duration of 30 min.
 

Keywords: Nalbuphine, Hemodynamics, Pneumoperitoneum, Laparoscopic surgery.

How to cite : Singhal M, Rautela R S, Salhotra R, Hirani K, Kumar M, Efficacy of nalbuphine for suppression of hemodynamic responses to pneumoperitoneum- A prospective randomised controlled study. Indian J Clin Anaesth 2023;10(1):58-63

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.